Strides Pharma Science Limited has informed the Exchange about Schedule of meet
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma Science has informed exchanges that its management will participate in a non-deal road show (NDRS) across four US cities from June 2–5, 2026. The road show includes one-on-one in-person meetings with analysts and institutional investors in New York, Chicago, Salt Lake City, and Los Angeles. The Q4 FY26 earnings presentation (already uploaded on May 18, 2026) will serve as the discussion document during these meetings. The filing is dated May 28, 2026, and signed by Company Secretary Manjula Ramamurthy.
This is a routine investor relations activity with no direct material impact on the stock. However, it signals the company's proactive engagement with global institutional investors and could generate positive sentiment if discussions highlight business growth or new pipeline developments.